1. Home
  2. EPWK vs CINGW Comparison

EPWK vs CINGW Comparison

Compare EPWK & CINGW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EPWK
  • CINGW
  • Stock Information
  • Founded
  • EPWK 2011
  • CINGW N/A
  • Country
  • EPWK China
  • CINGW United States
  • Employees
  • EPWK N/A
  • CINGW 13
  • Industry
  • EPWK
  • CINGW Biotechnology: Pharmaceutical Preparations
  • Sector
  • EPWK
  • CINGW Health Care
  • Exchange
  • EPWK Nasdaq
  • CINGW Nasdaq
  • Market Cap
  • EPWK N/A
  • CINGW N/A
  • IPO Year
  • EPWK 2025
  • CINGW 2021
  • Fundamental
  • Price
  • EPWK $9.40
  • CINGW $0.04
  • Analyst Decision
  • EPWK
  • CINGW
  • Analyst Count
  • EPWK 0
  • CINGW 0
  • Target Price
  • EPWK N/A
  • CINGW N/A
  • AVG Volume (30 Days)
  • EPWK 597.3K
  • CINGW N/A
  • Earning Date
  • EPWK 05-27-2025
  • CINGW N/A
  • Dividend Yield
  • EPWK N/A
  • CINGW N/A
  • EPS Growth
  • EPWK N/A
  • CINGW N/A
  • EPS
  • EPWK N/A
  • CINGW N/A
  • Revenue
  • EPWK $20,164,008.00
  • CINGW N/A
  • Revenue This Year
  • EPWK N/A
  • CINGW N/A
  • Revenue Next Year
  • EPWK N/A
  • CINGW N/A
  • P/E Ratio
  • EPWK N/A
  • CINGW N/A
  • Revenue Growth
  • EPWK 10.25
  • CINGW N/A
  • 52 Week Low
  • EPWK $3.80
  • CINGW N/A
  • 52 Week High
  • EPWK $26.00
  • CINGW N/A
  • Technical
  • Relative Strength Index (RSI)
  • EPWK N/A
  • CINGW N/A
  • Support Level
  • EPWK N/A
  • CINGW N/A
  • Resistance Level
  • EPWK N/A
  • CINGW N/A
  • Average True Range (ATR)
  • EPWK 0.00
  • CINGW 0.00
  • MACD
  • EPWK 0.00
  • CINGW 0.00
  • Stochastic Oscillator
  • EPWK 0.00
  • CINGW 0.00

About CINGW Cingulate Inc.

Cingulate Inc is a clinical-stage biopharmaceutical company utilizing its proprietary precision timed-release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes. The company focuses on the treatment of Attention Deficit/Hyperactivity Disorder (ADHD) and anxiety, and identifying and evaluating additional therapeutic area to use PTR technology to develop future product candidates.

Share on Social Networks: